Druq approval process
FDA Associate Com-.for Management and Operations Gerald Meyer has been given a temporary collateral assignment to assist in streamlining the drug approval process. Deputy Com. Norris announced the appointment at an FDA policy board meeting July 12. During Meyer's assignment, which is for an unspecified time period, Deputy Associate Com. for Management and Operations Sharon Smith Holston will assume day-to-day duties of Associate Com.
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."